Study of LQT-1213 on Dofetilide-Induced QTc Prolongation in Healthy Adult Subjects and Patients Diagnosed With Type 2 or 3 Long QT Syndrome
Condition: Long QT Syndrome Interventions: Drug: LQT-1213; Drug: Placebo; Drug: Dofetilide 250 μg Cap Sponsor: Thryv Therapeutics, Inc. Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials